Neonatal Intensive Care Unit

4

Review clinical trials related to Neonatal Intensive Care Unit. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Maternal Sensory Interventions in Newborns

This study was designed to determine the effects of maternal sensory interventions (kangaroo care, lullabies, and maternal tactile-auditory soothing) on sleep-wake states, physiological parameters, and sleep onset latency in newborns admitted to the neonatal intensive care unit.

Participants needed: 80
Trial details
Age: 35-42Biological sex: AllType: InterventionalSponsor: Kirsehir Ahi Evran UniversitesiUpdated: Jul 27, 2026Locations: 1
Eligibility criteria

Gestational age between 35 and 42 completed weeks. [+5]

Five-minute Apgar score <4. [+7]

Status: Recruiting

The Effect of Gentle Human Touch and Stimulus Reduction on Pain and Comfort During Heel Blood Collection in Premature Newborns

Premature infants frequently experience painful procedures during their admission to neonatal intensive care units; this can lead to acute adverse events, imbalances, and long-term neurodevelopmental implications. This randomized controlled trial evaluates the impact of Gentle Human Touch (GHT) and rate change (eye mask and earplug) on pain and comfort during heel prick blood collection in premature infants (32-36+6 weeks gestational age). A total of 60 infants were randomly assigned to three groups: GHT, rate change, and standard care (pacifier). Pain was assessed using the Premature Infant Pain Profile-Revised (PIPP-R), and comfort was measured before, during, and after the procedure using the COMFORTneo operator. Physiological impact (heart rate, oxygen saturation) and propagation time were recorded. The findings provide evidence for safe and effective non-pharmacological interventions in pain management and their inclusion in developmental care protocols.

Participants needed: 60
Trial details
Age: 32-37Biological sex: AllType: InterventionalSponsor: Kubra Nur Kabakcı SarıdağUpdated: Jul 20, 2026Locations: 1
Eligibility criteria

Preterm infants with a gestational age between 32 and 36+6 weeks [+1]

Infants with serious medical conditions that may affect study parameters [+1]

Status: Recruiting

Critical Care Optimized Pediatric and Neonatal Quantitative Neuromonitoring

The detection and appropriate treatment of seizures significantly impact the neurological prognosis of patients in intensive care. Indeed, altered brain function including seizures is described in critically ill children, regardless of the reason for admission. Most seizures are subclinical and therefore impossible to diagnose without neuromonitoring tools. Despite being concidered ad Gold Standard, continuous EEG (cEEG) with video recording shows difficulty of implementation and interpretation at all hours of the day and night explaining that less than 10% of centers in France use cEEG routinely. Most departments prefer simplified techniques, including amplitude traces (aEEG) which can be used continuously at the bedside. However, the positive predictive value of aEEG in the detection of seizures does not exceed 78% and 64% in newborns and children respectively making necessary an optimization of the information provided by these techniques. This project is a pragmatic diagnostic study that aims at developing and evaluating a neuromonitoring interface adapted to the needs of pediatric and neonatal intensive care units and meeting the requirements of neurophysiologists in terms of EEG trace quality.

Participants needed: 120
Trial details
Age: Up to 24Biological sex: AllType: ObservationalSponsor: Nantes University HospitalUpdated: Mar 10, 2026Locations: 1
Eligibility criteria

Patients younger than 2 years old hospitalized in the intensive care unit with a... [+2]

Parents who do not understand French. [+2]

Status: Recruiting

Pasteurised Donor Human Milk Supplementation for Term Babies

PRESENT is a multi-center randomised controlled trial that aims to assess whether access to pasteurized donor human milk as supplementary nutrition in the first five days of life for term infants born to women with diabetes in pregnancy reduces the proportion of infants who are admitted to a neonatal unit for management of hypoglycemia compared with current standard hospital care. The trial will also assess other important outcomes including breastfeeding rates, maternal mental health, and infant cow's milk allergy. There will be two treatment arms. In the intervention arm, PDHM will be made available to infants from randomisation until day 5 of life. Infants allocated to the control arm will receive care as per local unit policy, including supplemental nutrition as recommended by the treating clinician. After hospital discharge, participants will be asked to complete an electronic questionnaire at 2 \& 6 weeks and 6 \& 12 months after birth. Questionnaires will assess infant feeding practices, maternal quality of life \[including anxiety and depression symptoms and health-related quality of life\] along with infant cow's milk allergy symptoms.

Participants needed: 1,444
Trial details
Phase: Phase 4Age: 0-48Biological sex: AllType: InterventionalSponsor: The University of QueenslandUpdated: Feb 2, 2026Locations: 4
Eligibility criteria

Mother is >18 years at the time of consent [+5]

Multiple pregnancy [+5]